Navigation Links
Sinovac Obtains Lot Release Certificate for Its First Batch of H1N1 Vaccine

target='_new' target='_new'>" target="_new">

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the business outlook and quotations from management in this press release contain forward-looking statements. Statements that are not historical facts, including statements about Sinovac's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. Sinovac does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

    For more information, please contact:

    Sinovac Biotech Ltd.:
     Helen G. Yang
     Tel:   +86-10-8289-0088 x9871
     Fax:   +86-10-6296-6910

     Stephanie Carrington / Janine McCargo
     The Ruth Group
     Tel:   +1-646-536-7033
     Email: /

SOURCE Sinovac Biotech Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sinovac Announces Postponement of Annual General Meeting
2. Sinovac Requests Extension for Annual Shareholders Meeting
3. Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
4. Sinovac Closes $9.75 Million Private Placement
5. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
6. Sinovac Announces Adjournment of Annual General Meeting
7. Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2007 Financial Results
8. Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results
9. Sinovac Biotech Holds Annual General Meeting
10. Sinovac to Present at the Brean Murray, Carret & Co. All-Cap All-China Conference and the Roth China Discovery Tour 2008
11. Sinovac Receives RMB 20 Million Purchase Order for Healive from Chinas Ministry of Health to Vaccinate Earthquake Victims
Post Your Comments:
(Date:10/7/2015)... ... October 07, 2015 , ... ... webinar titled Smart Nanostructured Coatings to provide a comprehensive overview of the innovations ... free webinar at . This webinar will be given by Professor ...
(Date:10/7/2015)... Menlo Park, CA and Yokahama, Japan (PRWEB) , ... ... ... Sugiyama Lab at RIKEN have entered into a collaborative agreement to develop a ... interactions (DDIs). , Optivia and the Sugiyama Lab will combine their respective ...
(Date:10/6/2015)... ... October 06, 2015 , ... Researchers ... microscope technology that could help surgeons work with a greater degree of accuracy. ... blood flow and cancerous tissue over real images of blood vessels and other ...
(Date:10/6/2015)... , Oct. 6, 2015  The nonprofit ... that natural ingredients manufacturer Teawolf has adopted the ... Adopt-an-Herb Program . HerbMedPro ™ database ... clinical research on guayusa, a caffeine-containing member of ... comprehensive database available on ABC,s website that provides ...
Breaking Biology Technology:
... Networks Corp. has been recognized by Microsoft ... services. , ,The Madison-based IT solutions provider this month ... Midwest to achieve Microsoft's Enterprise Project Management (EPM) specialization. ... expertise in serving businesses that require the tools and ...
... Wis. Higher revenue from its clinical molecular diagnostic products ... a loss for the quarter ending March 31, 2006. , ,Third ... of $4.4 million, or ($0.11) a diluted share, for the first ... net loss of $4.4 million, or ($0.11) a diluted share, for ...
... Wis. Fiserv, which provides software and services ... revenues in 2006 were up 13 percent to $1.1 ... from the $140 million the company made in the ... , ,Fiserve's activities in the first quarter included repurchasing ...
Cached Biology Technology:
(Date:9/28/2015)... , September 28, 2015 ... Component (Hardware & Software), Product (Scanner & Others), Application ... & Defense, & Others) & Geography Global - Forecast ... expected to reach USD 3627.90 Million by 2020, at ... Browse 65 market data T ables ...
(Date:9/24/2015)... , Sept. 24, 2015  EyeLock LLC, a ... showcasing its award winning and latest technology in Booth ... Anaheim, California . EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:9/10/2015)... LONDON , Sept. 10, 2015 ... This New Study Reveals Selling Opportunities and Revenue ... What,s the future of biologics, especially new drug ... You will stay ahead with exclusive market data ... can explore trends, developments, results, opportunities and sales ...
Breaking Biology News(10 mins):
... is often compared to a book. However, it is not so ... rather like a cookbook. The cell reads only those recipes which ... genes; ,reading, in the book of the cell means creating RNA ... The cell uses highly complex, sophisticated regulatory mechanisms to ...
... have created mice that can "smell" light, providing a potent ... basis of olfaction. The work, described this week in ... future study of smell and of complex perception systems that ... "It makes intuitive sense to use odors to study ...
... thousand federal, state and local leaders and physical security ... Regional Airport next May 17-19 to observe demonstrations of ... to personnel, equipment and facilities - in combat zones ... and abroad. Military and civilian representatives of ...
Cached Biology News:
... for all types of yeast two-hybrid studies, including complex ... Choice of two bait vectors for maximum ... Triple reporter strain NMY51 ... Complete set of controls: pLexA-p53, pLexA-lamin ...
... Quickly, effectively seals labware. Waterproof, ... protects anhydrous materials. Can be folded ... without rupturing. Stretched lengthwise at 21C ... Yet when tension is removed, film ...
Human Serum FDA Licensed US Donor Centers Sterile / Non-sterile: Sterile Filtered to 0.2 micron Information: Extensive Viral Testing ...
Normal human serum collected off the clot from healthy normal humans. Each donor unit is negative for anti-HIV 1&2, HIV-Ag, HCV, and HBsAg by FDA required tests...
Biology Products: